<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report two pediatric patients with unusual, aggressive initial manifestation of <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome secondary to <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The first patient, a 13-year-old girl, presented with bilateral <z:e sem="disease" ids="C0376288" disease_type="Disease or Syndrome" abbrv="">amaurosis</z:e> and ischemic <z:e sem="disease" ids="C0221505" disease_type="Disease or Syndrome" abbrv="">cerebral lesions</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The second, another 13-year-old girl, presented with cerebral venous sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> and membranous <z:hpo ids='HP_0000099'>glomerulonephritis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Both patients improve after treatment with <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> and immunosuppressive drugs, two therapies that are aimed at modulating the immune response or towards preventing <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>However, there is no consensus regarding the duration and intensity of oral anticoagulation in children with <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome </plain></SENT>
</text></document>